Allografts | Medical XPRT
Articles & Whitepapers
-
Beyond Insulin: Immunotherapy for Type 1 Diabetes-PI
Type 1 diabetes (T1D) is a complex T-cell-mediated autoimmune disease that results in the destruction of insulin-producing beta cells and inadequate insulin secretion. Prior to the discovery of insulin in 1921, patients with T1D died within a year or two of diagnosis. Since the discovery and mass production of insulin, T1D is no longer a terminal disease. However, over time, many patients still ...
News
-
Cerapedics Announces FDA approval of an IDE supplement
Cerapedics, a private ortho-biologics company, today announced the U.S. Food and Drug Administration (FDA) has approved the company’s Investigational Device Exemption (IDE) supplement, reducing the enrollment requirement for the on-going ...
Cerapedics Announces Results from Clinical Trial of i-FACTOR Peptide Enhanced Bone Graft in Lumbar Fusion Surgery
Axogen to Participate at Upcoming Investor Conferences
Axogen, Inc. to Report Fourth Quarter and Full-Year 2021 Financial Results and Host Conference Call on February 22, 2022
Axogen to Participate at AAHS ASPN ASRM 2022 Annual Meetings
Equipment & Solutions
-
Showcase
Slow-Healing or Chronic Wound
Designed by nature, made for healing. Do you have a slow-healing or chronic wound? This could be a diabetic foot ulcer, a venous leg ulcer, or other difficult-to-heal wounds. It is important that these serious wounds with damaged skin receive the advanced care needed to avoid complications ranging from infection to even amputation. Application of TheraSkin — a real human skin allograft ...
